OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+8.67%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$89.3M
AUM Growth
+$89.3M
(-29%)
Cap. Flow
-$45.8M
Cap. Flow
% of AUM
-51.29%
Top 10 Holdings %
Top 10 Hldgs %
48.24%
Holding
68
New
4
Increased
2
Reduced
48
Closed
7
Top Buys
| 1 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$2.43M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$1.77M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$1.11M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$905K |
| 5 |
CKPT
Checkpoint Therapeutics
CKPT
|
$530K |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$5.02M |
| 2 |
iShares Biotechnology ETF
IBB
|
$3.88M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$3.27M |
| 4 |
Alkermes
ALKS
|
$2.41M |
| 5 |
Incyte
INCY
|
$2.19M |
Sector Composition
| 1 | Healthcare | 78.16% |
| 2 | Real Estate | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
26
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.4M | 1.29% | 15,000 -15,000 | -50% | -$1.4M |
|
27
Pacira BioSciences
PCRX
$1.2B
| $1.19M | 1.09% | 25,000 -25,000 | -50% | -$1.19M |
|
|
ALXN
28
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.16M | 1.06% | 9,526 -9,175 | -49% | -$1.12M |
|
|
LOXO
29
DELISTED
Loxo Oncology, Inc
LOXO
| $1.11M | 1.01% | +13,800 | New | +$1.11M |
|
30
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$647M
| $1.01M | 0.92% | 16,002 +7,279 | +83% | +$459K |
|
|
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $964K | 0.88% | 40,000 -40,000 | -50% | -$964K |
|
|
32
Karyopharm Therapeutics
KPTI
$61.7M
| $905K | 0.83% | +100,000 | New | +$905K |
|
33
Axsome Therapeutics
AXSM
$6.05B
| $734K | 0.67% | 133,500 -133,500 | -50% | -$734K |
|
|
TSRO
34
DELISTED
TESARO, Inc.
TSRO
| $699K | 0.64% | 5,000 -5,000 | -50% | -$699K |
|
|
KITE
35
DELISTED
Kite Pharma, Inc.
KITE
| $613K | 0.56% | 5,915 -16 | -0.3% | -$1.66K |
|
|
JUNO
36
DELISTED
Juno Therapeutics, Inc.
JUNO
| $537K | 0.49% | 17,970 -60 | -0.3% | -$1.79K |
|
|
MDCO
37
DELISTED
Medicines Co
MDCO
| $532K | 0.49% | 14,000 -14,000 | -50% | -$532K |
|
|
CKPT
38
DELISTED
Checkpoint Therapeutics
CKPT
| $530K | 0.49% | +117,760 | New | +$530K |
|
39
Myriad Genetics
MYGN
$593M
| $527K | 0.48% | 20,414 -70 | -0.3% | -$1.81K |
|
|
ADMS
40
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $525K | 0.48% | 30,000 -30,000 | -50% | -$525K |
|
41
Precigen
PGEN
$1.34B
| $442K | 0.4% | 18,345 -66 | -0.4% | -$1.59K |
|
|
SNR
42
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $421K | 0.39% | 41,850 -41,850 | -50% | -$421K |
|
|
SIOX
43
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $404K | 0.37% | 17,425 | – | – |
|
44
Ultragenyx Pharmaceutical
RARE
$2.89B
| $382K | 0.35% | 6,157 -6,044 | -50% | -$375K |
|
45
Akebia Therapeutics
AKBA
$833M
| $302K | 0.28% | 21,009 -21,010 | -50% | -$302K |
|
46
Grifois
GRFS
$6.78B
| $272K | 0.25% | 12,885 -9,047 | -41% | -$191K |
|
47
IQVIA
IQV
$32.4B
| $261K | 0.24% | 2,921 -2,106 | -42% | -$188K |
|
48
Charles River Laboratories
CRL
$8.04B
| $259K | 0.24% | 2,562 -1,879 | -42% | -$190K |
|
49
Ligand Pharmaceuticals
LGND
$3.15B
| $257K | 0.24% | 2,113 -1,606 | -43% | -$195K |
|
50
Bio-Techne
TECH
$8.5B
| $248K | 0.23% | 2,112 -1,678 | -44% | -$197K |
|